英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Trimethoprim |
甲氧芐啶 |
738-70-5 |
詳細(xì)
|
Rifaximin |
利福昔明 |
80621-81-4 |
詳細(xì)
|
HCV-IN-3 |
HCV-IN-3 |
1401839-25-5 |
詳細(xì)
|
HDAC-IN-4 |
Compound 7 |
1252003-13-6 |
詳細(xì)
|
HDAC-IN-5 |
HDAC-IN-5 |
1314890-51-1 |
詳細(xì)
|
hDDAH-1-IN-2 |
hDDAH-1-IN-2 |
2408834-77-3 |
詳細(xì)
|
HDACs/mTOR Inhibitor 1 |
HDACS/MTOR INHIBITOR 1 |
2271413-06-8 |
詳細(xì)
|
H3B-6545 |
H3B-6545 |
2052130-80-8 |
詳細(xì)
|
IDH1 Inhibitor 2 |
IDH1 INHIBITOR 2 |
2244895-42-7 |
詳細(xì)
|
IDH1 Inhibitor 3 |
IDH1 INHIBITOR 3 |
2171081-24-4 |
詳細(xì)
|
HAT-IN-1 |
HAT-IN-1 |
1889281-94-0 |
詳細(xì)
|
Haloperidol (D4');Haloperidol D4' |
鹵橄欖-D4 |
136765-35-0 |
詳細(xì)
|
Hck-IN-1 |
Nef-IN-B9 |
1473404-51-1 |
詳細(xì)
|
HCV-IN-30 |
達(dá)卡他韋中間體II |
1007882-23-6 |
詳細(xì)
|
HCV-IN-29 |
1H-咪唑, 5,5'-[1,1'-聯(lián)苯]-4,4'-雙[2-(2S)-2-吡咯烷鹽酸鹽 (1:4) |
1009119-83-8 |
詳細(xì)
|
HCV-IN-7 hydrochloride |
化合物 T11548L |
1449756-87-9 |
詳細(xì)
|
Helioxanthin 8-1;Helioxanthin analogue 8-1 |
11-(1,3-苯并二氧雜環(huán)戊烯-5-基)-8,9-二氫-1,3-苯并二氧雜環(huán)戊烯并[4,5-G]酞嗪-7,10-二酮 |
840529-13-7 |
詳細(xì)
|
HET0016 |
化合物 T11556 |
339068-25-6 |
詳細(xì)
|
Helvolic acid;Fumigacin |
煙麴黴酸 |
29400-42-8 |
詳細(xì)
|
Helioxanthin derivative 5-4-2;Helioxanthin 5-4-2 |
CS-1214 |
203935-39-1 |
詳細(xì)
|
Haemanthamine |
NSC403140 |
466-75-1 |
詳細(xì)
|
H4R antagonist 1 |
H4R ANTAGONIST 1 |
1429375-54-1 |
詳細(xì)
|
hDHODH-IN-1 |
hDHODH-IN-1 |
1173715-42-8 |
詳細(xì)
|
HIV-1 inhibitor-3 |
1-((2R,3R,4S,5S)-3,5-二氟-4-羥基-5-(羥甲基)四氫呋喃-2-基)嘧啶-2,4(1H,3H)-二酮 |
1612841-22-1 |
詳細(xì)
|
Histone Acetyltransferase Inhibitor II |
組蛋白乙酰轉(zhuǎn)移酶 抑制劑II |
932749-62-7 |
詳細(xì)
|
HIF-2α-IN-3 |
化合物 T11562 |
313964-19-1 |
詳細(xì)
|
HIF-2α-IN-2 |
HIF2α-IN-2 |
1672666-82-8 |
詳細(xì)
|
Heptamidine dimethanesulfonate |
SBi4211 dimethanesulfonate |
161374-55-6 |
詳細(xì)
|
Mebendazole |
甲苯達(dá)唑 |
31431-39-7 |
詳細(xì)
|
Haloperidol D4 |
氟哌啶醇-D4氘代標(biāo)記 |
1189986-59-1 |
詳細(xì)
|
HA155;CS-963 |
CS-963 |
1312201-00-5 |
詳細(xì)
|
HCV-IN-7 |
HCV-IN-7 |
1449756-86-8 |
詳細(xì)
|
hDHODH-IN-2 |
|
183946-00-1 |
詳細(xì)
|
Palonosetron hydrochloride |
鹽酸帕洛諾司瓊 |
135729-62-3 |
詳細(xì)
|
Hexyl gallate |
沒食子酸己酯 |
1087-26-9 |
詳細(xì)
|
hGPR91 antagonist 1 |
(S)-2-(4-(1,8-萘啶-2-基)苯基)-N-(1-(4'-氟-3'-(三氟甲基)-[1,1'-聯(lián)苯]-4-基)乙基)乙酰胺 |
1314796-00-3 |
詳細(xì)
|
FASN-IN-3 |
FASN inhibitor 1 |
2097262-60-5 |
詳細(xì)
|
HG-12-6 |
HG-12-6 |
2222354-57-4 |
詳細(xì)
|
hDDAH-1-IN-1 |
hDDAH-1-IN-1 |
1229238-69-0 |
詳細(xì)
|
hDDAH-1-IN-1 TFA |
|
1229238-70-3 |
詳細(xì)
|
Heptasaccharide Glc4Xyl3 |
低聚七糖,氣液色譜法4XYL3 |
121591-98-8 |
詳細(xì)
|
Heptamidine;SBi4211 |
4-[7-(4-carbamimidoylphenoxy)heptoxy]benzenecarboximidamide |
94345-47-8 |
詳細(xì)
|
Cathepsin Inhibitor 2 |
1017931-53-1 |
1017931-53-1 |
詳細(xì)
|
GW311616 hydrochloride;GW311616A |
CS-1260 |
197890-44-1 |
詳細(xì)
|
GW311616 |
CS-1261 |
198062-54-3 |
詳細(xì)
|
H3B-6545 Hydrochloride |
化合物 T11530 |
2052132-51-9 |
詳細(xì)
|
H3B-120 |
H3B-120 |
2194903-42-7 |
詳細(xì)
|
H-Ser-His-OH |
H-Ser-His-OH |
67726-09-4 |
詳細(xì)
|
H100 |
643727-55-3 |
643727-55-3 |
詳細(xì)
|
DPP-IV-IN-2 |
136259-18-2 |
136259-18-2 |
詳細(xì)
|
HS80 |
HS80 |
2138838-57-8 |
詳細(xì)
|
BAY 59-9435;HSL-IN-2 |
化合物 T11577 |
654059-21-9 |
詳細(xì)
|
HSL-IN-1 |
化合物 T11576 |
2095156-13-9 |
詳細(xì)
|
HL271 |
HL271 |
1422365-52-3 |
詳細(xì)
|
HIV-1 integrase inhibitor 4 |
1638504-66-1 |
1638504-66-1 |
詳細(xì)
|
HS79 |
HS79 |
2138838-56-7 |
詳細(xì)
|
Moxidectin |
莫西菌素 |
113507-06-5 |
詳細(xì)
|
HLY78 |
化合物HLY78 |
854847-61-3 |
詳細(xì)
|
HKI-357 |
HKI 357 |
848133-17-5 |
詳細(xì)
|
HPN-01 |
HPN-01 |
928655-63-4 |
詳細(xì)
|
Encequidar |
HM 30181A |
849675-66-7 |
詳細(xì)
|
Encequidar mesylate |
849675-87-2 |
849675-87-2 |
詳細(xì)
|
HSL-IN-3 |
2-(5,5-二甲基-1,3,2-二氧硼雜烷-2-基)苯甲酸乙酯 |
346656-34-6 |
詳細(xì)
|
HIV-1 integrase inhibitor 3 |
1638504-56-9 |
1638504-56-9 |
詳細(xì)
|
HIV-1 integrase inhibitor |
4-[3-(疊氮基甲基)苯基]-2-羥基-4-氧代-2-丁烯酸 |
544467-07-4 |
詳細(xì)
|
HIV-1 integrase inhibitor 7 |
HIV-1 integrase inhibitor 7 |
204268-03-1 |
詳細(xì)
|
Hydroxy ziprasidone |
齊拉西酮羥基化雜質(zhì) |
884305-08-2 |
詳細(xì)
|
Hydroxy desmethyl Bosentan;Ro 64-1056 |
波生坦羥甲基O-去甲基雜質(zhì) |
253688-62-9 |
詳細(xì)
|
HWL-088 |
HWL-088 |
2378617-96-8 |
詳細(xì)
|
HSV-TK substrate |
HSV-TK SUBSTRATE |
111687-37-7 |
詳細(xì)
|
HSR6071 |
111374-21-1 |
111374-21-1 |
詳細(xì)
|
Heme Oxygenase-1-IN-1 hydrochloride;HO-1-IN-1 hydrochloride |
HO-1-IN-1 HYDROCHLORIDE |
1092851-70-1 |
詳細(xì)
|
Heme Oxygenase-1-IN-1;HO-1-IN-1 |
HO-1-IN-1 |
1093058-52-6 |
詳細(xì)
|
Phenoxybenzamine hydrochloride |
鹽酸酚芐明 |
63-92-3 |
詳細(xì)
|
Hydroxyamine hydrochloride |
鹽酸羥胺 |
5470-11-1 |
詳細(xì)
|
Hydroxybupropion |
羥基安非他酮 |
92264-81-8 |
詳細(xì)
|
Hydroxycitric acid tripotassium hydrate;Potassium citrate monohydrate |
檸檬酸鉀一水合物 |
6100-05-6 |
詳細(xì)
|
(-)-Hydroxycitric acid;Garcinia acid |
5-羥基吲哚-2-羧酸 |
27750-10-3 |
詳細(xì)
|
Hydroxyzine D4 |
Hydroxyzine d4 |
2070014-84-3 |
詳細(xì)
|
Leflunomide |
來氟米特 |
75706-12-6 |
詳細(xì)
|
Idelalisib D5;CAL-101 D5;GS-1101 D5 |
Idelalisib D5 |
1830330-31-8 |
詳細(xì)
|
Prothionamide |
丙硫異煙胺 |
14222-60-7 |
詳細(xì)
|
Epanolol;Visacor;ICI141292 |
依泮洛爾 |
86880-51-5 |
詳細(xì)
|
Ibrutinib dimer |
依魯替尼雜質(zhì)9 |
2031255-23-7 |
詳細(xì)
|
Ibrutinib-MPEA |
Ibrutinib-MPEA |
1710768-30-1 |
詳細(xì)
|
Ibuprofen-d3;(±)-Ibuprofen D3;Ibuprofen D3 |
氘代布洛芬 |
121662-14-4 |
詳細(xì)
|
(-)-Ibuprofenamide;(R)-Ibuprofenamide |
(-)-Ibuprofenamide |
121839-78-9 |
詳細(xì)
|
ICI 118,551 hydrochloride |
ICI 118,551 HYDROCHLORIDE |
72795-01-8 |
詳細(xì)
|
ICI 153110 |
ICI 153110 |
87164-90-7 |
詳細(xì)
|
IACS-9571;ASIS-P040 |
IACS9571 |
1800477-30-8 |
詳細(xì)
|
I-OMe-Tyrphostin AG 538 |
I-OME-AG 538 |
1094048-77-7 |
詳細(xì)
|
IAXO-102 |
IAXO-102 |
1115270-63-7 |
詳細(xì)
|
IACS-8803 |
IACS-8803 |
2095690-70-1 |
詳細(xì)
|
IACS-8779 |
IACS-8779 |
2243079-26-5 |
詳細(xì)
|
I2906 |
1-乙基-1,2-二氫-4-羥基-2-氧代-3-喹啉羧酸 2-(1-氧代十三烷基)酰肼 |
331963-29-2 |
詳細(xì)
|
Hydroxyzine D8 |
安泰樂D8 |
1189480-47-4 |
詳細(xì)
|
Ibiglustat (L-Malic acid) |
1629063-78-0 |
1629063-78-0 |
詳細(xì)
|
Fusidic acid |
夫西地酸 |
6990-06-3 |
詳細(xì)
|
Ibrutinib-d5;PCI-32765 D5;Ibrutinib D5 |
伊布替尼布D5 |
1553977-17-5 |
詳細(xì)
|
IBR2 |
313526-24-8 |
313526-24-8 |
詳細(xì)
|